参考文献/References:
[1] Aller SG,Yu J,Ward A,et al.Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding[J].Science,2009,323(5922):1718-1722.
[2] Kannan P,John C,Zoghbi SS,et al.Imaging the function of P-glycoprotein with radiotracers:pharmacokinetics and in vivo applications[J].Clin Pharmacol Ther,2009,86(4):368-377.
[3] Hendrikse NH,Schinkel AH,de Vries EG,et al.Complete in vivo reversal of P-glycoprotein pump function in the blood-brain barrier visualized with positron emission tomography[J],Br J Pharmacol,1998,124(7):1413-1418.
[4] Hendrikse NH,de Vries EG,Eriks-Fluks L,et al.A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier[J].Cancer Res,1999,59(10):2411-2416.
[5] Sasongko L,Link JM,Muzi M,et al.Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomography[J].Clin Pharmacol Ther,2005,77(6):503-514.
[6] Chung FS,Eyal S,Muzi M,et al.Positron emission tomography imaging of tissue P-glycoprotein activity during pregnancy in the non-human primate[J].Br J Pharmacol,2010,159(2):394-404.
[7] Eyal S,Chung FS,Muzi M,et al.Simultaneous PET imaging of P-glycoprotein inhibition in multiple tissues in the pregnant nonhuman primate[J].J Nucl Med,2009,50(5):798-806.
[8] Zoghbi SS,Liow JS,Yasuno F,et al.11C-loperamide and its N-desmethyl radiometabolite are avid substrates for brain permeability-glycoprotein efflux[J].J Nucl Med,2008,49(4):649-656.
[9] Kreisl WC,Liow JS,Kimura N,et al.P-glycoprotein function at the blood-brain barrier in humans can be quantified with the substrate radiotracer 11C-N-desmethyl-loperamide[J].J Nucl Med,2010,51(4):559-566.
[10] Lazarova N,Zoghbi SS,Hong J,et al.Synthesis and evaluation of[N-methyl-11C] N-desmethyl-loperamide as a new and improved PET radiotracer for imaging P-gp function[J].J Med Chem,2008,51(19):6034-6043.
[11] Liow JS,Kreisl W,Zoghbi SS,et al.P-glycoprotein function at the blood-brain barrier imaged using 11C-N-desmethyl-loperamide in monkeys[J].J Nucl Med,2009,50(1):108-115.
[12] Seneca N,Zoghbi SS,Shetty HU,et al.Effects of ketoconazole on the biodistribution and metabolism of[11C]loperamide and[11C]N-desmethyl-loperamide in wild-type and P-gp knockout mice[J].Nucl Med Biol,2010,37(3):335-345.
[13] Jonsson O,Behnam-Motlagh P,Persson M,et al.Increase in doxorubicin cytotoxicity by carvedilol inhibition of P-glycoprotein activity[J].Biochem Pharmacol 1999,58(11):1801-1806.
[14] Bart J,Dijkers EC,Wegman TD,et al.New positron emission tomography tracer[11C]carvedilol reveals P-glycoprotein modulation kinetics[J].Br J Pharmacol,2005,145(8):1045-1051.
[15] Luna-Tortos C,Fedrowitz M,Loscher W,et al.Several major antiepileptic drugs are substrates for human P-glycoprotein[J].Neuropharmacology,2008,55(8):1364-1375.
[16] Baron JC,Roeda D,Munari C,et al.Brain regional pharmacokinetics of 11C-labeled diphenylhydantoin:positron emission tomography in humans[J].Neurology,1983,33(5):580-585.
[17] Schinkel AH,Mayer U,Wagenaar E,et al.Normal viability and altered pharmacokinetics in mice lacking mdr1-type(drug-transporting) P-glycoproteins[JJ.Proc Natl Acad Sci USA,1997,94(8):4028-4033.
[18] Kiesewetter DO,Jagoda EM,Kao CH,et al.Fluoro-,bromo-,and iodopaclitaxel derivatives:synthesis and biological evaluation[J].Nucl Med Biol,2003,30(1):11-24.
[19] Hsueh WA,Kesner AL,Gangloff A,et al.Predicting chemotherapy response to paclitaxel with 18F-Fluoropaclitaxel and PET[J].J Nucl Med,2006,47(12):1995-1999.
[20] Lacan G,Plenevaux A,Rubins DJ,et al.Cyclosporine,a P-glycoprotein modulator,increases[18F] MPPF uptake in rat brain and peripheral tissues:microPET and ex vivo studies[J].Eur J Nucl Med Mol Imaging,2008,35(12):2256-2266.
[21] Kawamura k,Yamasaki T,Yui J,et al.In vivo evaluation of P-glycoprotein and breast cancer resistance protein modulation in the brain using[11C]gefitinib[J].Nucl Med Biol,2009,36(3):239246.
[22] Levchenko A,Mehta BM,Lee JB,et al.Evaluation of 11C-colchicine for PET imaging of multiple drug resistance[J].J Nucl Med,2000,41(3):493-501.
[23] van Waarde A,Ramakrishnan NK,Rybczynska AA,et al.Synthesis and preclinical evaluation of novel PET probes for P-glycoprotein function and expression[J].J Med Chem,2009,52(14):4524-4532.
[24] Seo S,Hatano E,Higashi T,et al.P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro[J].Int J Oncol,2009,34(5):1303-1312.
[25] Yu C,Wan W,Zhang B,et al.Evaluation of the relationship between[18F] FDG and P-glycoprotein expression:an experimental study[J].Nucl Med Biol 2012,39(5):671-678.
[26] Luurtsema G,Schuit RC,Klok RP,et al.Evaluation of[11C]laniquidar as a tracer of P-glycoprotein:radiosynthesis and biodistribution in rats[J].Nucl Med Biol,2009,36(6):643-649.
[27] Dorner B,Kuntner C,Bankstahl JP,et al.Synthesis and small-animal positron emission tomography evaluation of[11C]-elacridar as a radiotracer to assess the distribution of P-glycoprotein at the blood-brain barrier[J].J Med Chem,2009,52(19):6073-6082.
[28] Kawamura K,Yamasaki T,Konno F,et al.Evaluation of limiting brain penetration related to P-glycoprotein and breast cancer resistance protein using[11C]GF120918 by PET in mice[J].Mol Imaging Biol,2011,13(1):152-160.
[29] Bauer F,Kuntner C,Bankstahl JP,et al.Synthesis and in vivo evaluation of[11C]tariquidar,a positron emission tomography radiotracer based on a third-generation P-glycoprotein inhibitor[J].Bioorg Med Chem,2010,18(15):5489-5497.
[30] Kawamura K,Konno F,Yui J,et al.Synthesis and evaluation of[11C]XR9576 to assess the function of drug efflux transporters using PET[J].Ann Nucl Med,2010,24(5):403-412.
[31] Yamasaki T,Kawamura K,Hatori A,et al.PET study on mice bearing human colon adenocarcinoma cells using[11C]GF120918,a dual radioligand for P-glycoprotein and breast cancer resistance protein[J].Nucl Med Commun,2010,31(11):985-993.
[32] Kannan P,Brimacombe KR,Zoghbi SS,et al.N-desmethyl-loperamide is selective for P-glycoprotein amony three ATP-binding cassette transporters at the blood-brain[J].Drug Metab Dispos,2010,38(6):917-922.
[33] Kawamura K,Yamasaki T,Konno F,et al.Synthesis and in vivo evaluation of 18F-fluoroethyl GF120918 and XR9576 as positron emission tomography probes for assessing the function of drug efflux transporters[J].Bioorg Med Chem,2011,19(2):861-870.
[34] Mairinger S,ErkerT,Muller M,et al.PET and SPECT radiotracers to assess function and expression of ABC transporters in vivo[J].Curr Drug Metab 2011,12(8):774-792.
相似文献/References:
[1]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[2]胡伟,赵军.小胶质细胞在AD炎性机制中的作用及其常见PET显像剂的应用进展[J].国际放射医学核医学杂志,2016,40(1):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
Hu Wei,Zhao Jun.Microglia’s Alzheimer disease inflammatory mechanisms and progress of its common application in PET imaging agents[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):44.[doi:10.3760/cma.j.issn.1673-4114.2016.01.009]
[3]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[4]李海峰,张晓军,李云钢,等.国产模块LOOP环改良法合成11C-蛋氨酸[J].国际放射医学核医学杂志,2016,40(2):106.[doi:10.3760/cma.j.issn.1673-4114.2016.02.004]
Li Haifeng,Zhang Xiaojun,Li Yungang,et al.Synthesis of 11C-methionine on home-made module by the improved LOOP method[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):106.[doi:10.3760/cma.j.issn.1673-4114.2016.02.004]
[5]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[6]李海峰,张晓军,张锦明.多巴胺转运蛋白显像剂11C-β-CFT在帕金森病中的应用研究[J].国际放射医学核医学杂志,2016,40(3):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
Li Haifeng,Zhang Xiaojun,Zhang Jinming.Review of the use of dopamine transporter imaging agent 11C-β-CFT for diagnosing Parkinson disease[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):218.[doi:10.3760/cma.j.issn.1673-4114.2016.03.011]
[7]尤阳,轩昂,张杰,等.淋巴瘤患者大脑静息葡萄糖代谢改变[J].国际放射医学核医学杂志,2016,40(4):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
You Yang,Xuan Ang,Zhang Jie,et al.Changes in resting-state brain glucose metabolism in patients with lymphoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):255.[doi:10.3760/cma.j.issn.1673-4114.2016.04.003]
[8]王朋,崔邦平,代文莉,等.18F-FDG PET/CT在前列腺癌中的应用进展[J].国际放射医学核医学杂志,2016,40(4):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
Wang Peng,Cui Bangping,Dai Wenli,et al.Progress in the application of 18F-FDG PET/CT in prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):277.[doi:10.3760/cma.j.issn.1673-4114.2016.04.008]
[9]李菲,黄俊星,张俊.18F-FDG PET/CT在食管癌中的临床应用[J].国际放射医学核医学杂志,2016,40(4):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
Li Fei,Huang Junxing,Zhang Jun.The clinical application of 18F-FDG PET/CT in esophageal cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):282.[doi:10.3760/cma.j.issn.1673-4114.2016.04.009]
[10]张巍,杨珂.18f正电子放射性药物生产及使用中医务人员的受照剂量研究[J].国际放射医学核医学杂志,2015,39(5):420.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 016]
zhang wei,yang ke..the research of radiation dose of 18f-fdg to pet/ct related personnel[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):420.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 016]
[11]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]